Mineralys Therapeutics (NASDAQ:MLYS) Downgraded by Wall Street Zen to “Sell”
Wall Street Zen lowered shares of Mineralys Therapeutics (NASDAQ:MLYS – Free Report) from a hold rating to a sell rating in a report published on Saturday. Other equities analysts have also issued research reports about the stock. Jefferies Financial Group began coverage on shares of Mineralys Therapeutics in a research report on Tuesday. They set […]
Wall Street Zen lowered shares of Mineralys Therapeutics (NASDAQ:MLYS – Free Report) from a hold rating to a sell rating in a report published on Saturday. Other equities analysts have also issued research reports about the stock. Jefferies Financial Group began coverage on shares of Mineralys Therapeutics in a research report on Tuesday. They set […]
